876316-36-8Relevant articles and documents
N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity
Abeywardane, Asitha,Caviness, Gary,Choi, Younggi,Cogan, Derek,Gao, Amy,Goldberg, Daniel,Heim-Riether, Alexander,Jeanfavre, Debra,Klein, Elliott,Kowalski, Jennifer A.,Mao, Wang,Miller, Craig,Moss, Neil,Ramsden, Philip,Raymond, Ernest,Skow, Donna,Smith-Keenan, Lana,Snow, Roger J.,Wu, Frank,Wu, Jiang-Ping,Yu, Yang
, p. 5277 - 5283 (2016/11/11)
Compound 1 ((4-amino-3,5-dichlorophenyl)-1-(4-methylpiperidin-1-yl)-4-(2-nitroimidazol-1-yl)-1-oxobutane-2-sulfonamido) was discovered to be a 690 nM antagonist of human CCR10 Ca2+flux. Optimization delivered (2R)-4-(2-cyanopyrrol-1-yl)-S-(1H-indol-4-yl)-1-(4-methylpiperidin-1-yl)-1-oxobutane-2-sulfonamido (eut-22) that is 300 fold more potent a CCR10 antagonist than 1 and eliminates potential toxicity, mutagenicity, and drug–drug-interaction liabilities often associated with nitroaryls and anilines. eut-22 is highly selective over other GPCR's, including a number of other chemokine receptors. Finally, eut-22 is efficacious in the murine DNFB model of contact hypersensitivity. The efficacy of this compound provides further evidence for the role of CCR10 in dermatological inflammatory conditions.